Free Trial

Artivion (AORT) Competitors

Artivion logo
$31.08 -0.16 (-0.50%)
Closing price 03:59 PM Eastern
Extended Trading
$31.06 -0.03 (-0.10%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AORT vs. BLCO, IRTC, SLNO, TMDX, INSP, NVST, PRCT, WRBY, LIVN, and EYE

Should you be buying Artivion stock or one of its competitors? The main competitors of Artivion include Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), and National Vision (EYE). These companies are all part of the "medical equipment" industry.

Artivion vs. Its Competitors

Bausch + Lomb (NYSE:BLCO) and Artivion (NYSE:AORT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Artivion has a net margin of -5.49% compared to Bausch + Lomb's net margin of -7.50%. Artivion's return on equity of 3.63% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-7.50% 2.62% 1.28%
Artivion -5.49%3.63%1.34%

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 86.4% of Artivion shares are held by institutional investors. 0.8% of Bausch + Lomb shares are held by company insiders. Comparatively, 7.6% of Artivion shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bausch + Lomb has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Artivion has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500.

In the previous week, Artivion had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 6 mentions for Artivion and 5 mentions for Bausch + Lomb. Artivion's average media sentiment score of 0.91 beat Bausch + Lomb's score of 0.58 indicating that Artivion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Artivion
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Bausch + Lomb currently has a consensus price target of $15.45, suggesting a potential upside of 9.96%. Artivion has a consensus price target of $32.40, suggesting a potential upside of 4.23%. Given Bausch + Lomb's higher possible upside, equities research analysts clearly believe Bausch + Lomb is more favorable than Artivion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Artivion
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

Artivion has lower revenue, but higher earnings than Bausch + Lomb. Artivion is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$4.79B1.04-$317M-$1.03-13.65
Artivion$388.54M3.42-$13.36M-$0.50-62.17

Summary

Artivion beats Bausch + Lomb on 14 of the 17 factors compared between the two stocks.

Get Artivion News Delivered to You Automatically

Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AORT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AORT vs. The Competition

MetricArtivionMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$1.33B$6.86B$5.70B$21.16B
Dividend YieldN/A1.27%4.59%3.57%
P/E Ratio-62.1718.3220.9824.41
Price / Sales3.4264.59443.3258.80
Price / Cash37.4420.6736.5523.00
Price / Book4.724.728.634.67
Net Income-$13.36M$176.14M$3.24B$993.85M
7 Day Performance0.77%1.68%3.22%1.16%
1 Month Performance-0.06%3.77%10.72%4.99%
1 Year Performance10.94%6.45%34.94%12.54%

Artivion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AORT
Artivion
2.9247 of 5 stars
$31.09
-0.5%
$32.40
+4.2%
+11.8%$1.33B$388.54M-62.171,600News Coverage
BLCO
Bausch + Lomb
2.1922 of 5 stars
$13.67
-1.5%
$15.45
+13.1%
-16.3%$4.83B$4.83B-13.2713,500News Coverage
Upcoming Earnings
IRTC
iRhythm Technologies
1.3141 of 5 stars
$138.91
+2.2%
$138.60
-0.2%
+34.4%$4.43B$591.84M-44.242,000Positive News
Upcoming Earnings
SLNO
Soleno Therapeutics
3.7846 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+80.7%$4.17BN/A-17.9130Positive News
High Trading Volume
TMDX
TransMedics Group
2.3525 of 5 stars
$116.88
+3.9%
$127.33
+8.9%
-29.2%$3.95B$441.54M85.94210Positive News
Upcoming Earnings
INSP
Inspire Medical Systems
4.9002 of 5 stars
$130.17
-0.1%
$211.91
+62.8%
-5.3%$3.84B$802.80M59.981,246Positive News
Analyst Forecast
NVST
Envista
3.5158 of 5 stars
$20.05
-0.8%
$20.23
+0.9%
+27.8%$3.40B$2.51B-3.0712,300Upcoming Earnings
PRCT
PROCEPT BioRobotics
2.7815 of 5 stars
$58.17
+2.7%
$87.50
+50.4%
-13.5%$3.22B$249.12M-34.22430Upcoming Earnings
WRBY
Warby Parker
2.6956 of 5 stars
$23.02
+3.7%
$22.88
-0.6%
+47.4%$2.41B$795.09M-191.803,780News Coverage
Insider Trade
LIVN
LivaNova
3.3354 of 5 stars
$43.97
-0.8%
$59.29
+34.8%
-19.2%$2.40B$1.25B-10.752,900Upcoming Earnings
EYE
National Vision
2.8177 of 5 stars
$25.01
+2.2%
$22.10
-11.6%
+91.6%$1.98B$1.82B-75.7913,411Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:AORT) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners